Sun, Dec 28, 2014, 3:35 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Compugen Ltd. (CGEN) Message Board

  • cheapalias cheapalias Jan 28, 2013 10:50 AM Flag

    CGEN Presentations

    Ok saw the update(see below) and I have a question maybe someone can answer...Mary Haak-Frendscho, Ph.D., board chairman of SF CGEN office is also CEO,of Igenica, Inc. and she is also presenting at the TRI-CON event....so is Igenica a competitor or a potential partner to CGEN..??? Can anyone explain her duality of interests?

    Events

    Dr.John Hunter, VP, Antibody Research & Development , Compugen Inc., to present at the Molecular Med TRI-CON 2013| Feb 11,2013 - Feb 15,2013
    Finding Suitable Targets for Cancer Biologics...also presenting

    Mary Haak-Frendscho, Ph.D., CEO,Igenica, Inc.

    Considerations for sourcing primary samples
    Balancing novelty with known biology
    Identifying pathways and signaling systems
    Assessing penetrance and abundance of expression
    Engaging the patient's immune response
    Increasing tumor delivery and penetration

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Re: Mary Haak-Frendscho: She still serves as the COB for Compugen Inc (the subsidiary in SF). When she initially took that role, she committed to working full-time for CGEN on a temporary basis to establish the SF operation. Once that work was completed, she stepped back into a traditional advisory Chairperson role, thus allowing her to work full-time for another company while still acting in the best interests of CGEN. I believe this plan was discussed in the 2nd quarter call last year. Dr John Hunter is head of the SF site for daily operations.

      Sentiment: Strong Buy

 
CGEN
8.69+0.11(+1.28%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Fluor Corporation
NYSEFri, Dec 26, 2014 4:03 PM EST